The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Pulmonary Embolism Market Projected To Become By 2030 Based On Its 2026 Valuation?
The pulmonary embolism market has experienced rapid expansion in recent years. It is anticipated to increase from $2.26 billion in 2025 to $2.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The growth observed in the historical period stems from factors such as a rise in the incidence of cardiovascular and thromboembolic disorders, the expansion of hospital emergency care services, broader utilization of anticoagulant medications, increasing awareness of pulmonary embolism symptoms, and the availability of advanced diagnostic imaging.
The market size for pulmonary embolism is projected to experience significant growth in the coming years, with an expectation to reach $4.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. This projected growth can be attributed to several factors including increased investments in advanced anticoagulant medications, the rising implementation of catheter-based intervention techniques, the expansion of early diagnostic screening initiatives, a heightened focus on outpatient management strategies, and an increasing demand for personalized cardiovascular care. Prominent trends anticipated within this forecast period involve the growing adoption of novel anticoagulant therapies, an increase in the use of minimally invasive thrombectomy devices, an intensified focus on early and precise diagnosis, the broadening of integrated care pathways, and a greater emphasis on risk stratification and prevention.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp
What Primary Drivers Are Shaping The Development Of The Pulmonary Embolism Market?
The rising incidence of cancer is expected to fuel the expansion of the pulmonary embolism market. Cancer refers to a collection of diseases typified by the uncontrolled and irregular multiplication of cells throughout the body. A higher prevalence of cancer increases the risk of blood clot formation, such as pulmonary embolism, in patients with the disease. This subsequently drives a greater demand for diagnostic methods and treatments, including specialized pharmaceuticals. For example, in January 2024, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, indicated that the count of cancer cases grew to 2,001,140 from 1,958,310 in 2023, marking a 2.19% increase. Consequently, the increasing occurrence of cancer is propelling the growth of the pulmonary embolism market.
What Segment Groups Are Identified Within The Pulmonary Embolism Market?
The pulmonary embolism market covered in this report is segmented –
1) By Treatment: Medications, Mechanical Devices, Other Treatments
2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis
3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medications: Anticoagulants, Thrombolytics
2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy
3) By Other Treatments: Surgical Embolectomy, Supportive Care
What Key Trends Are Influencing The Development Of The Pulmonary Embolism Market?
Leading companies in the pulmonary embolism market are dedicated to creating advanced products like the Triever16 Curve catheter and the RevCore thrombectomy catheter to achieve a market advantage. For example, Inari Medical Inc., a US-based medical device firm, unveiled both the Triever16 Curve catheter and the RevCore thrombectomy catheter in June 2023. The innovative Triever16 Curve catheter is specifically developed for peripheral thrombectomy and pulmonary embolism procedures, boasting high trackability and a pre-shaped curve for precise aspiration. Its unique design also provides simple access for larger, more powerful 20F or 24F catheters. Concurrently, the RevCore thrombectomy catheter is engineered to manage venous in-stent thrombosis, operating as a mechanical thrombectomy device that employs a nitinol basket to capture and eliminate blood clots. Moreover, these catheters contribute to improving the overall safety and effectiveness of pulmonary embolism interventions.
Which Companies Hold Significant Positions In The Pulmonary Embolism Market?
Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A
Read the full pulmonary embolism market report here:
https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report
How Does The Pulmonary Embolism Market Perform Across Major Global Regions?
North America was the largest region in the pulmonary embolism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary embolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pulmonary Embolism Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp
Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2026, By The Business Research Company
Psychiatrists Market
https://www.thebusinessresearchcompany.com/report/psychiatrists-market
Oncologists Global Market Report
https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report
Mental Health Global Market Report
https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model